Inventor · disambiguated record
Fotios M. Plakogiannis
Also filed as: PLAKOGIANNIS FOTIOS · PLAKOGIANNIS FOTIOS M
17 granted patents·25 pending applications·8 citations·filing 2011–2025
88Inventor score
Files withPIKE THERAPEUTICS INC20STARTON THERAPEUTICS INC9AEQUUS PHARMACEUTICALS INC4PIKE THERAPEUTICS USA INC3ALPHA TO OMEGA PHARMACEUTICAL CONSULTANTS INC2
Top patents by PatentIndex Score
42 records- 0190US11197852B2Continuous delivery of lenalidomide and other immunomodulatory agentsSTARTON THERAPEUTICS INC·Filed 2020·Granted Dec 14, 2021·4 cites·18 claims
- 0284US12016829B2Pharmaceutical composition and method for treating seizure disordersPIKE THERAPEUTICS INC·Filed 2021·Granted Jun 25, 2024·1 cites·4 claims
- 0383US12121617B2Transdermal delivery of cannabidiolPIKE THERAPEUTICS INC·Filed 2021·Granted Oct 22, 2024·1 cites·21 claims
- 0482US12097293B2Transdermal delivery of cannabidiolPIKE THERAPEUTICS INC·Filed 2020·Granted Sep 24, 2024·1 cites·13 claims
- 0579US12383510B2Treatment of vomiting and nausea with minimum dose of olanzapineSTARTON THERAPEUTICS INC·Filed 2024·Granted Aug 12, 2025·0 cites·19 claims
- 0676US2025108043A1Continuous delivery of lenalidomide and other immunomodulatory agentsSTARTON THERAPEUTICS INC·Filed 2024·Application pending·0 cites
- 0775US12268699B2Transdermal delivery of tetrahydrocannabinolPIKE THERAPEUTICS INC·Filed 2024·Granted Apr 8, 2025·0 cites·21 claims
- 0873US2024261235A1Pharmaceutical Composition And Method For Treating Seizure DisordersPIKE THERAPEUTICS INC·Filed 2024·Application pending·0 cites
- 0969US12201622B2Continuous delivery of lenalidomide and other immunomodulatory agentsSTARTON THERAPEUTICS INC·Filed 2021·Granted Jan 21, 2025·0 cites·18 claims
- 1069US10500196B2Transdermal and/or topical delivery systems composed of doxylamine succinate and pyridoxine hydrochloride in combination, or aloneAEQUUS PHARMACEUTICALS INC·Filed 2016·Granted Dec 10, 2019·1 cites·10 claims
- 1168US10624901B2Transdermal and/or topical delivery system comprising clobazamALPHA TO OMEGA PHARMACEUTICAL CONSULTANTS INC·Filed 2019·Granted Apr 21, 2020·0 cites·16 claims
- 1268US2022047541A1Pharmaceutical compositions and methods for treating parkinson's diseasePIKE THERAPEUTICS INC·Filed 2021·Application pending·0 cites
- 1368US2022047525A1Transdermal pharmaceutical formulations of nabilone alone and in combination with cannabinoidsPIKE THERAPEUTICS INC·Filed 2021·Application pending·0 cites
- 1467US2025186363A1Pharmaceutical Compositions and Methods for Treating Parkinson's DiseasePIKE THERAPEUTICS INC·Filed 2025·Application pending·0 cites
- 1566US2025049821A1Pharmaceutical Composition and Method for Treating Seizure DisordersPIKE THERAPEUTICS INC·Filed 2024·Application pending·0 cites
- 1665US2024299372A1Transdermal Drug Delivery Systems for Administration of a Therapeutically Effective Amount of Apixaban and Other Direct Oral AnticoagulantsPIKE THERAPEUTICS INC·Filed 2024·Application pending·0 cites
- 1764US11975112B2Treatment of vomiting and nausea with minimum dose of olanzapineSTARTON THERAPEUTICS INC·Filed 2021·Granted May 7, 2024·0 cites·11 claims
- 1862US2025248948A1Transdermal and/or Topical, Pharmaceutical Formulations Comprising Cannabidiol and/or Tetrahydrocannabinol for the Treatment of Chronic PainPIKE THERAPEUTICS INC·Filed 2025·Application pending·0 cites
- 1962US2022000794A1Transdermal pharmaceutical formulations for the treatment of multiple sclerosisPIKE THERAPEUTICS INC·Filed 2021·Application pending·0 cites
- 2062US2024024253A1Continuous Drug Delivery Systems and MethodsPIKE THERAPEUTICS INC·Filed 2023·Application pending·0 cites
- 2161US2025312359A1Transdermal Delivery of TetrahydrocannabinolPIKE THERAPEUTICS INC·Filed 2025·Application pending·0 cites
- 2261US2021346310A1Transdermal and/or topical, pharmaceutical formulations comprising cannabidiol and/or tetrahydrocannabinol for the treatment of chronic painPIKE THERAPEUTICS INC·Filed 2021·Application pending·0 cites
- 2360US11717525B2Transdermal and/or topical delivery system comprising clobazamALPHA TO OMEGA PHARMACEUTICAL CONSULTANTS INC·Filed 2020·Granted Aug 8, 2023·0 cites·18 claims
- 2459US2023059204A1Transdermal micro-dosing delivery of pharmaceutical agentsPIKE THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 2557US12409132B2Transdermal delivery of dronabinolPIKE THERAPEUTICS USA INC·Filed 2021·Granted Sep 9, 2025·0 cites·4 claims
- 2657US2022347151A1Transdermal pharmaceutical formulations for the treatment of chronic painPIKE THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 2756US2021100737A1Transdermal delivery of dronabinolSTARTON THERAPEUTICS INC·Filed 2020·Application pending·0 cites
- 2855US2022395468A1Transdermal Drug Delivery Systems for Administration of a Therapeutically Effective Amount of Lenalidomide and Other Immunomodulatory AgentsSTARTON THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 2955US2022175718A1Transdermal pharmaceutical formulations for the treatment of cancerPIKE THERAPEUTICS INC·Filed 2021·Application pending·0 cites
- 3054US2024009204A1Treatment of Vomiting and Nausea with Minimum Dose of OlanzapineSTARTON THERAPEUTICS INC·Filed 2021·Application pending·0 cites
- 3154US2025381205A1Transdermal Delivery of DronabinolPIKE THERAPEUTICS USA INC·Filed 2025·Application pending·0 cites
- 3253US2021322447A1Transdermal micro-dosing delivery of psychedelics derivativesPIKE THERAPEUTICS INC·Filed 2021·Application pending·0 cites
- 3352US10449201B2Transdermal and/or topical delivery system comprising clobazamAEQUUS PHARMACEUTICALS INC·Filed 2016·Granted Oct 22, 2019·0 cites·15 claims
- 3452US2022040194A1Use of olanzapine for treatment of parp-inhibitor-induced nauseaSTARTON THERAPEUTICS INC·Filed 2019·Application pending·0 cites
- 3551US12186280B2Pharmaceutical composition and method for treating seizure disordersPIKE THERAPEUTICS INC·Filed 2020·Granted Jan 7, 2025·0 cites·16 claims
- 3651US2023123388A1Transdermal and/or topical delivery system comprising hydroxychloroquine and/or chloroquineGLANIS PHARMACEUTICALS INC·Filed 2021·Application pending·0 cites
- 3751US2023139565A1Oral delivery system comprising hydroxychloroquine and/or chloroquineGLANIS PHARMACEUTICALS INC·Filed 2021·Application pending·0 cites
- 3850US12409131B2Transdermal delivery of dronabinolPIKE THERAPEUTICS USA INC·Filed 2021·Granted Sep 9, 2025·0 cites·14 claims
- 3946US2018250281A1Transdermal delivery of doxylamine succinate and pyridoxine hydrochlorideAEQUUS PHARMACEUTICALS INC·Filed 2018·Application pending·0 cites
- 4043US9757374B2Aripiprazole compositions and methods for its transdermal deliveryAEQUUS PHARMACEUTICALS INC·Filed 2015·Granted Sep 12, 2017·0 cites·16 claims
- 4137US9138402B2Aripiprazole compositions and methods for its transdermal deliveryPLAKOGIANNIS FOTIOS M·Filed 2011·Granted Sep 22, 2015·0 cites·4 claims
- 4233US2013171237A1Aripiprazole compositions and methods for its transdermal deliveryPLAKOGIANNIS FOTIOS M·Filed 2012·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Fotios M. Plakogiannis files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →